tirzepatide gip/glp-1 dual action drops gip/glp 1-agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes Dual GLP-1/GIP Agonist | Tirzepatide

87 , e63 (2019)

2024;26(Suppl 2):3445

Individuals with genetic variants in the GLP1R gene (such as rs6923761) or GIPR gene (rs1800437) may show differential receptor sensitivity, meaning a combination approach can activate multiple pathways more effectively than monotherapy alone

After your initial evaluation (which can also be done via telehealth), most follow-ups and protocol adjustments happen through telehealth appointments

Tirzepatide is administered subcutaneously once weekly and works by activating GIP and GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite

Semaglutide is a prescription drug that should only be used under the guidance of a doctor